Vassar College

Diakonos Oncology Appoints Biotech Veteran Anthony Baldor as Chief Financial Officer

Retrieved on: 
Monday, February 26, 2024
Research, Clinical Trials, Stem Cells, Biotechnology, Health, Pharmaceutical, General Health, Science, Oncology, Data science, Molecule, B cell, Research fellow, Strategic management, MBA, Business development, Vaccine, IPO, University, Therapy, Business, Vassar College, Venture round, Financial management, Jefferies, Partnership, Management

Diakonos Oncology Corp. (“Diakonos”), a clinical stage immuno-oncology company, announced today that Anthony Baldor has been appointed Chief Financial Officer.

Key Points: 
  • Diakonos Oncology Corp. (“Diakonos”), a clinical stage immuno-oncology company, announced today that Anthony Baldor has been appointed Chief Financial Officer.
  • Mr. Baldor brings 20 years of financial management experience in the biotech industry including fundraising, business development, and corporate strategy.
  • Mr. Baldor comes to Diakonos from 4D Molecular Therapeutics where he played critical leadership roles in the Series C, IPO and partnership activities as Vice President of Corporate Strategy and Development.
  • “Anthony Baldor is a critical and timely addition to the Diakonos management team,” said Diakonos Chief Executive Officer Mike Wicks.

Cboe Global Markets Announces Election of Erin Mansfield and Cecilia Mao to Board of Directors; Declares First-Quarter 2024 Dividend

Retrieved on: 
Friday, February 9, 2024
Cloud, Vassar College, Equifax, Oracle Corporation, CBOE, Acquisition, Commodity, University, Verisk Analytics, Barclays, Goldman Sachs, BATS Global Markets, FICO, Cboe Global Markets, Management

Additionally, its Board of Directors has declared a quarterly cash dividend of $0.55 per share of common stock for the first quarter of 2024.

Key Points: 
  • Additionally, its Board of Directors has declared a quarterly cash dividend of $0.55 per share of common stock for the first quarter of 2024.
  • The first-quarter 2024 dividend is payable on March 15, 2024, to stockholders of record as of February 29, 2024.
  • William M. Farrow, III, non-executive Chairman of the Board of Cboe Global Markets, said: "We are excited to welcome Erin Mansfield and Cecilia Mao to the Cboe Global Markets Board of Directors.
  • Additionally, Joe Ratterman has decided to step down from the Board of Directors of Cboe Global Markets.

Equal Rights Advocates and Lieff Cabraser Announce Class Action Lawsuit by Women Vassar Professors Over College’s Gender Pay Gap

Retrieved on: 
Wednesday, August 30, 2023
Class Action Lawsuit, Professional Services, Legal, Male, Vassar College, Teaching, Seven Sisters, Woman, The Seven Sisters, Movement, Emeritus, Student, Motivation, Equal Rights Advocates, Faculty, Gender, Female, Psychological Science, Nursing, Management, College, History, Physics

As classes began this week, most of the women full professors at Vassar College spoke out about long-standing pay discrimination, culminating in their filing today of a class action lawsuit.

Key Points: 
  • As classes began this week, most of the women full professors at Vassar College spoke out about long-standing pay discrimination, culminating in their filing today of a class action lawsuit.
  • Vassar is one of the Seven Sisters, a group of historically women’s colleges founded on the promise of gender equity.
  • According to the professors, average salary data reflect a gender pay gap at Vassar in every year for the last two decades.
  • Most troublingly, the professors allege this gap has grown over time, with the most recent data reflecting a 10 percent gender pay disparity at Vassar.

Pyxis Oncology Successfully Completes Acquisition of Apexigen

Retrieved on: 
Wednesday, August 23, 2023
P.C, Therapy, Par value, Vassar College, Pfizer, Sidley Austin, Antibody, Research and development, Development, Acquisition, Patient, Oncology nursing, CD40, Ladenburg Thalmann, Cancer, Conjugation, FACT, ADC, Wilson Sonsini Goodrich & Rosati, Antibody-drug conjugate, Cornell University, Fine chemical, Management, New York University, Philosophy

BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS) (“Pyxis Oncology” or the “Company”), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced the successful completion of its acquisition of Apexigen, Inc. (“Apexigen”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative antibody therapeutics for oncology, in an all-stock transaction valued at approximately $10.7 million. The combined company is positioned at the forefront of ADC innovation with a platform that now includes four key components: novel humanized antibody generation capabilities, an expanded library of linkers with improved stability, site specific conjugation chemistries, and optimized payloads.

Key Points: 
  • Xiaodong Yang, M.D., Ph.D., founder and former Chief Executive Officer of Apexigen, is joining the combined company as Distinguished Research Fellow.
  • With the closing of this transaction, Jakob Dupont, M.D., Executive Partner at Sofinnova Investments, was appointed as an Independent Director to the Pyxis Oncology Board of Directors.
  • “I’m pleased to join the Pyxis Oncology Board of Directors,” said Jakob Dupont.
  • Pyxis Oncology issued approximately 4.3 million shares of common stock as a result of this transaction, and immediately post-acquisition, Pyxis Oncology is expected to have 43,872,248 shares of common stock outstanding.

SavATree Bolsters Executive Team, Adds COO, CGO, VP of Partner Integration

Retrieved on: 
Tuesday, August 22, 2023
Xavier University, Tuck School of Business, General Electric, Accreditation, Ben, Marketing, Integration, Vassar College, Aviation, Walmart, Business, MBA, Economics, Amazon, Diapers.com, BEDFORD, Dartmouth, Crecco, CGO, Mergers and acquisitions, Growth, CommonBond, SVP, Environment, Family, Bachelor of Economics, Northern Kentucky University, Management, Becker, Orchard, Power, Partnership

BEDFORD HILLS, N.Y., Aug. 22, 2023 /PRNewswire-PRWeb/ -- SavATree, the industry leader in professional tree, shrub, and lawn care, today announced the addition of key members to its executive team. Ben Stevie has been appointed Chief Operating Officer (COO), succeeding current COO Don Becker, while Phil DeGisi assumes the role of Chief Growth Officer (CGO). These appointments come as SavATree accelerates national growth and lays the groundwork for expanding internationally.

Key Points: 
  • "The addition of Ben and Phil to our executive team marks a significant milestone for SavATree," states SavATree CEO Carmine Schiavone.
  • "The addition of Ben and Phil to our executive team marks a significant milestone for SavATree," states SavATree CEO Carmine Schiavone.
  • Most recently, Kyle Johnson has joined as VP of Integration, working closely with Kirk Crecco, SVP of Mergers and Partnerships.
  • We are excited about the future and will continue to add world-class talent to our organization as we grow," adds Schiavone.

PenFed Credit Union Promotes Four Leaders to Senior Vice President

Retrieved on: 
Thursday, August 10, 2023
USAA, News, Cleveland State University, TIAA Bank, College, Culture, Vassar College, Pentagon Federal Credit Union, DHI, Shepherd University, Veteran, McCarren, ATM, Bank of America, South State Bank, Digital, Bank, Wells Fargo, Social media, Management, Visa

TYSONS, Va., Aug. 10, 2023 /PRNewswire/ -- PenFed Credit Union, the nation's second-largest federal credit union, today announced the promotion of four leaders who will oversee home lending technology, the PenFed Foundation, payments and home lending operations:

Key Points: 
  • TYSONS, Va., Aug. 10, 2023 /PRNewswire/ -- PenFed Credit Union , the nation's second-largest federal credit union, today announced the promotion of four leaders who will oversee home lending technology, the PenFed Foundation, payments and home lending operations:
    Brian Kukwa, vice president of mortgage technology, has been promoted to senior vice president of home lending technology;
    Andrea McCarren, vice president of PenFed Digital, has been promoted to senior vice president of PenFed Digital and president of PenFed Foundation;
    Brad Patterson, vice president of payments, has been promoted to senior vice president of payments;
    Mary Rzucidlo, vice president of home loans, has been promoted to senior vice president of home loans operations and culture.
  • "As a CEO, one of my greatest privileges is promoting leaders from within," said PenFed President and CEO James Schenck.
  • "These four individuals will be instrumental in providing best-in-class service for our members and supporting our nation's defenders through the PenFed Foundation."
  • McCarren will continue to lead PenFed Digital and will serve as the president of the PenFed Foundation, a national 501(c)3 founded by PenFed Credit Union.

Boundless Bio Appoints Jami Rubin as Chief Financial Officer

Retrieved on: 
Monday, July 31, 2023
Oncology, Health, Genetics, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, DNA, Therapy, PJT Partners, Bio, Vassar College, ARCH Venture Partners, Cancer, History, A-DNA, Eli Lilly, Goldman Sachs, M&A, Partner, Patient, AbbVie, Mylan, Growth, Pfizer, Pharmaceutical industry

Boundless Bio , a clinical stage, next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) for patients with oncogene amplified cancers, today announced the appointment of Jami Rubin as Chief Financial Officer.

Key Points: 
  • Boundless Bio , a clinical stage, next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) for patients with oncogene amplified cancers, today announced the appointment of Jami Rubin as Chief Financial Officer.
  • “Jami is a distinguished life sciences industry leader, and we are thrilled to welcome her to Boundless Bio,” said Zachary Hornby, President and Chief Executive Officer of Boundless Bio.
  • Boundless Bio is pioneering an exciting new approach to addressing this large unmet need by developing ecDNA directed therapeutics.
  • Ms. Rubin was most recently Chief Financial Officer of EQRx, where she led the organization through a go public process that raised $1.35 billion.

Dr. David B. Nash and Healthmap Solutions Team Up to Improve Kidney Health

Retrieved on: 
Wednesday, July 12, 2023
Health administration, University, Health policy, Population health, Population Health Management, Vassar College, Senior advisor, MBA, Medicine, Acos, Wharton School of the University of Pennsylvania, American Journal, MD, Patient, Widener University Commonwealth Law School, Kidney, Jefferson College, Dentistry, Health, Book, American Journal of Medical Quality, Nursing, HealthMap, Economics

TAMPA, Fla., July 12, 2023 (GLOBE NEWSWIRE) -- David B. Nash, MD, MBA, widely considered as the pioneer of population health management, is teaming up with kidney population health management company Healthmap Solutions, Inc. (Healthmap) in a Senior Advisor capacity.

Key Points: 
  • TAMPA, Fla., July 12, 2023 (GLOBE NEWSWIRE) -- David B. Nash, MD, MBA, widely considered as the pioneer of population health management, is teaming up with kidney population health management company Healthmap Solutions, Inc. (Healthmap) in a Senior Advisor capacity.
  • Dr. Nash will focus on strategy and program innovations for Healthmap’s national kidney health management program to benefit health plans, healthcare providers, and kidney patients.
  • “We are excited to have a visionary of David Nash’s caliber supporting the Healthmap team,” said Healthmap CEO Eric Reimer.
  • “David was talking about population health long before it was called population health, and today he has a keen understanding of where medicine, technology, and economics converge.”

Cari Robinson Joins August as Senior Managing Director in New York

Retrieved on: 
Tuesday, July 11, 2023
Data, IBM, Senior, General counsel, Culture, Vassar College, Robinson, Former, M&A, Revlon, Law, Growth, Bankruptcy, Emory University School of Law, Computer security

NEW YORK, July 11, 2023 /PRNewswire/ -- August, a specialized strategic communications advisory firm, announced today that Cari Robinson has joined the firm as a Senior Managing Director based in New York. In this role, she will help lead client engagements with a focus on providing strategic communications and crisis management counsel to August's clients in high stakes litigation, investigations, and crisis situations. Robinson brings more than three decades of diverse legal and corporate experience to August's team of highly skilled professionals and subject-matter experts.

Key Points: 
  • Distinguished Former Fortune 1000 General Counsel and Assistant U.S. Attorney Deepens August's Expertise in High-Stakes Crisis Management, Litigation, Cybersecurity, and Data Breaches
    NEW YORK, July 11, 2023 /PRNewswire/ -- August , a specialized strategic communications advisory firm, announced today that Cari Robinson has joined the firm as a Senior Managing Director based in New York.
  • Robinson brings more than three decades of diverse legal and corporate experience to August's team of highly skilled professionals and subject-matter experts.
  • Most recently, Robinson served as General Counsel at Revlon, where she advised senior management on significant matters including litigation, cybersecurity, M&A, and bankruptcy.
  • "I am excited to join August and to bring my experience and expertise to a fast-growing firm," said Robinson.

ARCH Venture Partners Announces Appointment of Jami Rubin as Venture Partner

Retrieved on: 
Tuesday, May 23, 2023
PJT Partners, Vassar College, ARCH Venture Partners, History, Eli Lilly, ARCH, Goldman Sachs, AbbVie, Mylan, CFO, Therapy, Independent Board for Presbyterian Foreign Missions, Pfizer

CHICAGO, May 23, 2023 /PRNewswire/ -- ARCH Venture Partners today announced the appointment of life sciences industry veteran Jami Rubin as Venture Partner.

Key Points: 
  • CHICAGO, May 23, 2023 /PRNewswire/ -- ARCH Venture Partners today announced the appointment of life sciences industry veteran Jami Rubin as Venture Partner.
  • "I am thrilled to join the ARCH team as a Venture Partner.
  • I look forward to putting my decades of experience to work as a member of the ARCH team," said Rubin.
  • She is a former partner at Goldman Sachs where she was ranked as a top pharmaceutical analyst and partner at PJT Partners.